ConductScience.org, home

Paper58199

Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.

Sagar S and 6 others. Lancet, 1976. Cited by 197 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Papers, record 58199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58199

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
197
iCite
Relative citation ratio, by iCite
9.18
iCite
Revised in PubMed
2019-06-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sagar SS
2Nairn DD
3Stamatakis JDJ D
4Maffei FHF H
5Higgins AFA F
6Thomas DPD P
7Kakkar VVV V

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HeparinMajor topic
Hip JointMajor topic
Joint ProsthesisMajor topic
ThrombophlebitisMajor topic
Clinical Trials as Topic
Dihydroergotamine
Drug Evaluation
Female
Femoral Vein
Follow-Up Studies
Hematoma
Humans
Male
Middle Aged
Postoperative Complications
Prospective Studies
Pulmonary Embolism

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.

PMIDTitleJournalYearIn PapersSource
27,517,405Dextran prophylaxis in total hip replacement: A scintigraphic evaluation of the incidence of deep vein thrombosis and pulmonary embolus.Ir J Med Sci1979https://conductscience.org/library/papers/27517405PubMed
22,084,658New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty.Thrombosis2010https://conductscience.org/library/papers/22084658PubMed
8,929,385Prevalence of deep venous thrombosis in the lower extremities of children in the intensive care unit.Pediatr Radiol1996https://conductscience.org/library/papers/8929385PubMed
7,257,029The effects of low-dose heparin treatment on patients undergoing transvesical prostatectomy.Urol Res1981https://conductscience.org/library/papers/7257029PubMed
7,233,920Prevention of postoperative deep vein thrombosis in Sweden: results of a survey.World J Surg1980https://conductscience.org/library/papers/7233920PubMed
6,876,691Antithrombin III deficiency in ischaemic stroke.Klin Wochenschr1983https://conductscience.org/library/papers/6876691PubMed
6,767,449Prophylaxis of venous thromboembolism: analysis of cost effectiveness.Ann Surg1980https://conductscience.org/library/papers/6767449PubMed
6,355,715[Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].Langenbecks Arch Chir1983https://conductscience.org/library/papers/6355715PubMed
6,192,998The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6192998PubMed
6,188,763Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur.J Clin Pathol1983https://conductscience.org/library/papers/6188763PubMed
6,164,655Thromboembolism after hip surgery.Int Orthop1981https://conductscience.org/library/papers/6164655PubMed
1,655,136Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ1991https://conductscience.org/library/papers/1655136PubMed
1,336,131Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.Neurosurg Rev1992https://conductscience.org/library/papers/1336131PubMed
1,314,065Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.Arch Orthop Trauma Surg1992https://conductscience.org/library/papers/1314065PubMed
990,839Prevention of postoperative deep venous thrombosis.Br Med J1976https://conductscience.org/library/papers/990839PubMed
884,445Femoral vein thrombosis and total hip replacement.Br Med J1977https://conductscience.org/library/papers/884445PubMed
697,431Failure of low dose heparin to prevent pulmonary embolism after hip surgery or above the knee amputation.Ann Surg1978https://conductscience.org/library/papers/697431PubMed
656,796[Deep-vein thrombosis after hip replacement].Br Med J1978https://conductscience.org/library/papers/656796PubMed
466,100Can we really prevent postoperative pulmonary emboli?Br Med J1979https://conductscience.org/library/papers/466100PubMed
351,980The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.World J Surg1978https://conductscience.org/library/papers/351980PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/58199

GET https://conductscience.org/api/papers/v1/58199/cited_by?page=2